Bicycle Therapeutics plc American Depositary Receipt (BCYC) at a glance

Bicycle Therapeutics plc American Depositary Receipt (BCYC) is a micro-cap Healthcare company. It trades at $4.21, with a 0% profit margin and revenue decline of 91.1%. It does not pay a dividend. Vestovix scores it 33/100 overall. Its strongest dimension is Value (58/100) and its weakest is Growth (11/100). It carries above-market volatility, so expect larger swings.

Price
$4.21
Market cap
$282.7M
P/E ratio
n/a
Dividend yield
None
Beta
1.54
52-week range
$3.75 to $9.16
Vestovix Score33/ 100How this works
Value
58
Growth
11
Income
40
Safety
30
Momentum
18

Other Healthcare stocks

See all